Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres

European Journal of Neurology

Volumn 23, Issue 4, 2016, Pages 787-795

  Marin, B ^a,b   Beghi, E ^c   Vial, C ^d   Bernard, E ^d   Lautrette, G ^b   Clavelou, P ^e   Guy, N ^e   Lemasson, G ^f   Debruxelles, S ^f   Cintas, P ^g   Antoine, J C ^h   Camdessanche, J P ^h   Logroscino, G ⁱ   Preux, P M ^a,b   Couratier, P ^a,b  

^a UNIVERSITÉ DE LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d HÔPITAL NEUROLOGIQUE   (France)

^e SERVICE DE RHUMATOLOGIE   (France)

^f HÔPITAL PELLEGRIN   (France)

^g CHU PURPAN   (France)

^h HÔPITAL NORD   (France)

ⁱ UNIVERSITY OF BARI   (Italy)

Author keywords

Access and evaluation; Amyotrophic lateral sclerosis; Clinical audit; Healthcare quality; Practice guideline

Indexed keywords

AMITRIPTYLINE; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATROPINE; NEUROPROTECTIVE AGENT; RILUZOLE; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VITAMIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY DISORDER; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CHEMISTRY; CLINICAL PRACTICE; CLINICAL RESEARCH; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DELAYED DIAGNOSIS; DEPRESSION; DRUG WITHDRAWAL; ENTERIC FEEDING; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; HYPERSALIVATION; HYPERTRANSAMINASEMIA; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; MULTICENTER STUDY; NEUROIMAGING; NEUROLOGIST; NEUROPHYSIOLOGY; NONINVASIVE VENTILATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PALLIATIVE THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEX RATIO; SLOW VITAL CAPACITY; TERMINAL CARE; THERAPY DELAY; THROMBOSIS; TRACHEOSTOMY; CLINICAL TRIAL; EVALUATION STUDY; FRANCE; MIDDLE AGED; PROTOCOL COMPLIANCE; STANDARDS;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; FRANCE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC;

EID: 84958213882     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12941     Document Type: Article

References (16)

1. Andersen PM, Borasio GD, Dengler R, et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005; 12: 921-938.
2. Diagnosis ETFO, Management of Amyotrophic Lateral Sclerosis, Andersen PM, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) - revised report of an EFNS task force. Eur J Neurol 2012;19:360-375
3. Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73: 1227-1233.
4. Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73: 1218-1226.
5. Haute Autorité en Santé. Prise en charge des personnes atteintes de sclérose latérale amyotrophique. 2006. http://www.has-sante.fr/portail/upload/docs/application/pdf/Sclerose_laterale_amyotrophique_long.pdf. (accessed 25/6/2015).
6. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
7. Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
8. Marin B, Hamidou B, Couratier P, et al. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - the French register of ALS in Limousin (FRALim register). Eur J Neurol 2014; 21: 1292-1300.
9. Miller RG, Anderson F, Brooks BR, et al. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database. Ann Neurol 2009; 65(Suppl 1): S24-S28.
10. Bradley WG, Anderson F, Gowda N, et al. Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5: 240-244.
11. Paganoni S, Macklin EA, Lee A, et al. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener 2014; 15: 453-456.
12. Brooks BR. Problems in shortening the time to confirmation of ALS diagnosis: lessons from the 1st Consensus Conference, Chicago, May 1998. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1(Suppl 1): S3-S7.
13. Dubrovsky AL. Shortening the time to the diagnosis of amyotrophic lateral sclerosis: role of the neurologist. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1(Suppl 1): S65-S66.
14. Bede P, Oliver D, Stodart J, et al. Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives. J Neurol Neurosurg Psychiatry 2011; 82: 413-418.
15. Borasio GD, Shaw PJ, Hardiman O, et al. Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey. Amyotroph Lateral Scler Other Motor Neuron Disord 2001; 2: 159-164.
16. Karam CY, Paganoni S, Joyce N, et al. Palliative care issues in amyotrophic lateral sclerosis: an evidenced-based review. Am J Hosp Palliat Care 2016; 33: 84-92.